Observational studyActa oncologica (Stockholm, Sweden)2024

Prognostic factors and overall survival among patients with ovarian cancer in the pre-PARP inhibitor era: the OCRWE-Finland study.

Mari Lahelma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.